online life science articles

I. Thomson Reuters Life Sciences Connect

Dr Dinah Parums
Individual Contributor at Thomson Reuters Life Sciences Connect, 
2014 / 2015
http://lsconnect.thomsonreuters.com/author/dinah-parums/

26th May 2015
‘Indigenous’ Human Microbes – the Microbiota and the Microbiome. 
http://lsconnect.thomsonreuters.com/indigenous-human-microbes-the-microbiota-and-the-microbiome/    

25th Feb 2015
CARs (Chimeric Antigen Receptors): Where Are They Taking Us? 
https://lsconnect.thomsonreuters.com/cars-chimeric-antigen-receptors-taking-us/

17th Feb 2015
Can Accelerated Drug Approval in Oncology Go Any Faster? 
https://lsconnect.thomsonreuters.com/can-accelerated-drug-approval-oncology-go-faster/

9th Feb 2015:
Lipids Actually – A Year of Advances in Hyperlipidaemia Therapy. 
https://lsconnect.thomsonreuters.com/lipids-actually-year-advances-hyperlipidaemia-therapy/

21st October 2014:
A Dendritic Cell ‘Vaccine’ is a First for ‘Promising Innovative Medicine’ (PIM) Status in the U.K. Dinah Parums. 
http://lsconnect.thomsonreuters.com/dendritic-cell-vaccine-first-promising-innovative-medicine-pim-status-u-k/

7th October 2014:
‘Back to the Future:’ Bioimmunoadjuvants in Cancer Therapy  https://lsconnect.thomsonreuters.com/back-future-bioimmunoadjuvants-cancer-therapy

22nd July 2014:
The 'Danger Theory' of Immune Recognition: 60 years on from 'Self, Non-Self'
https://lsconnect.thomsonreuters.com/danger-theory-immune-recognition-60-years-self-non-self/

19th June 2014:
The Role of the Pathologist in Targeting Therapy in NSCLC.
https://lsconnect.thomsonreuters.com/role-pathology-in-nsclc-targeting-therapy/

11th June 2014:
Targeted Therapy in NSCLC Part VI: Immune Therapy
https://lsconnect.thomsonreuters.com/targeted-therapy-nsclc-part-vi-immune-therapy/

27th May 2014:
Targeted Therapy in NSCLC Part IV: ALK
http://lsconnect.thomsonreuters.com/targeted-therapy-nsclc-part-iv-alk/

21st May 2014:
Targeted Therapy in NSCLC Part III: VEGF/VEGFR
http://lsconnect.thomsonreuters.com/targeted-therapy-nsclc-part-iii-vegf-vegfr/

14th May 2014:
Targeted Therapy in NSCLC Part II: EGF/EGFR
http://lsconnect.thomsonreuters.com/targeted-therapy-nsclc-part-ii-egf-egfr/

6th May 2014:
Targeted Therapy in Non Small Cell Lung Cancer (NSCLC). Part I. Biologics 
http://lsconnect.thomsonreuters.com/biologics-non-small-cell-lung-cancer-nsclc-part-current-status-2014/

9th April 2014:
Dietary Fats vs. Carbohydrates and Coronary Artery Atherosclerosis
http://lsconnect.thomsonreuters.com/dietary-fats-vs-carbohydrates-coronary-artery-atherosclerosis/

2nd April 2014:
L-Carnitine and Ischaemic Heart Disease: A Story of ‘Mice and Men’
http://lsconnect.thomsonreuters.com/l-carnitine-ischaemic-heart-disease-story-mice-men/

18th March 2014:
‘Crowdfunding’ and its Supporting Role in Life Science and Healthcare Projects.
http://lsconnect.thomsonreuters.com/crowdfunding-life-sciences/

 12th March 2014:
What's TRND-ing ? NIH Division of Pre-Clinical Innovation, subdivision of Therapeutics for Rare and Neglected Diseases (TRND).
http://lsconnect.thomsonreuters.com/whats-trnd-ing-nih-division-pre-clinical-innovation-subdivision-therapeutics-rare-neglected-diseases/

5th March 2014:
Collaboration Between the NIH, ‘Big Pharma’ and Non-Profit Organizations
http://lsconnect.thomsonreuters.com/collaboration-nih-big-pharma-non-profit-organisations/

 24th February 2014:
The National Center for Advancing Translational Sciences (NCATS): We May Be No Longer ‘Lost in Translation’
http://lsconnect.thomsonreuters.com/national-center-advancing-translational-sciences-ncats-may-longer-lost-translation/


II. LinkedIn Pulse

14th August 2015:
Medical Journalism: time for involvement by the medical profession. By Dr Dinah Parums  https://www.linkedin.com/pulse/medical-journalism-time-involvement-profession-dinah-parums


13th August 2015:
Good Publication Practice Guideline 3 (GPP3). August 2015. By Dr Dinah Parums
https://www.linkedin.com/pulse/good-publication-practice-guideline-3-gpp3-august-2015-dinah-parums?trk=prof-post



III. Contributing Author. Healthcare-Arena, 
published by Pentland Medical. Original Articles
https://healthcare-arena.co.uk/author/dinahparums/

11th August 2015
Is There a Role for Humour in Medicine? By Dr Dinah Parums
If so, what is it? For Healthcare-Arena. Illustrated by Fran Orford
https://healthcare-arena.co.uk/is-there-a-role-for-humour-in-medicine/

27th July 2015
Chronic Hepatitis C Infection. By Dr Dinah Parums. 
NHS England has now agreed to increase the funding of new treatments. For Healthcare-Arena. Illustrated by Fran Orford. https://healthcare-arena.co.uk/chronic-hepatitis-c-infection/

27th July 2015
The NHS Goes Back to the Future in 2015. By Dr Dinah Parums.
NHS England’s CEO outlines the implementation of the ‘Five Year Forward View’ at this year’s NHS Confederation conference. For Healthcare-Arena. 
https://healthcare-arena.co.uk/the-nhs-goes-back-to-the-future-in-2015/

27th July 2015
Meningitis B Vaccine. By Dr Dinah Parums
England and Scotland are first to implement a national vaccination programme: but who will follow? For Healthcare-Arena.  https://healthcare-arena.co.uk/meningitis-b-vaccine/

27th July 2015
Social Prescribing. By Dr Dinah Parums.
See your GP and leave with a prescription for a pet or a new hobby? For Healthcare-Arena. Illustrated by Fran Orford. https://healthcare-arena.co.uk/social-prescribing/

20th July 2015
Treatment for Advanced Melanoma Using T-VEC. By Dr Dinah Parums.
A Herpes Simplex Virus Type 1-derived oncolytic immunotherapy: - separating fact from fiction. Illustrated by Fran Orford.
https://healthcare-arena.co.uk/treatment-for-advanced-melanoma-using-t-vec/

20th July 2015
Personalised Microbial Health. By Dr Dinah Parums.
Microbiome data now being gathered may form the basis for a ‘personalised’ approach to improving individual microbial populations
https://healthcare-arena.co.uk/personalised-microbial-health/

20th July 2015
The Carter Review. Procurement in the NHS. By Dr Dinah Parums.
Standardisation is predicted to save the NHS £5bn a year by 2020.
https://healthcare-arena.co.uk/the-carter-review-procurement-in-the-nhs/

20th July 2015
Carbapenem-Resistant Enterobacteriaceae (CRE): an Update. By Dr Dinah Parums.
Antimicrobial Research Collaborative (ARC) recommends CRE screening as a priority for admissions to high-risk specialties
https://healthcare-arena.co.uk/carbapenem-resistant-enterobacteriaceae-cre/



IV. Marketing Product Insights - for Pentland Medical

11th August 2015
ABLiS™ – Antimicrobial Basin and Liner System. Pentland Medical Product Insight written by Dr Dinah Parums.
An innovative bed-bathing system providing cost-effective comfort and prevention of healthcare-associated infection (HAI)
https://healthcare-arena.co.uk/ablis-antimicrobial-basin-and-liner-system/

27th July 2015
Medspira Breath Hold. Pentland Medical Product Insight written by Dr Dinah Parums.
Safe, reliable, accurate and affordable respiratory control technology to protect patients during imaging and radiotherapy
https://healthcare-arena.co.uk/medspira-breath-hold/

20th July 2015
The Nasal Alar SpO2 Sensor. Pentland Medical Product Insight written by Dr Dinah Parums.
Accurate long-term pulse oximetry monitoring with greater patient comfort, lower cost and application beyond the ICU.
https://healthcare-arena.co.uk/the-nasal-alar-spo2-sensor/

---